WHY WE DIFFER

Medicine is slow to adopt new technology. This challenge is compounded for pediatric patients as they are often less of a priority.

As with most areas of medicine, insurance dictates which treatments get used. In this case, even though WatchPAT is an FDA approved home sleep technology, insurance traditionally has covered in-lab (overnight) hospital-based testing for younger patients.

The charge for a typical in-lab study is between $1,500 and $3,000 and requires a considerable investment of time from parents. Most sleep labs recognize this as significant revenue. As such, little has occurred to encourage insurance companies to cover home sleep testing as an alternative for adolescent patients.

The massive barriers to pediatric testing have created a significantly underserved area of medicine. Under the traditional in-lab sleep study pathway, parents only option has been to undergo a long, difficult, and expensive process that involves multiple trips to a sleep clinic and an overnight stay in a hospital.

SLEEPSIGHT can help parents quickly and easily determine if sleep apnea is a concern. This information can help guide decisions made by their healthcare providers and may determine if a need truly exists for a more invasive and expensive overnight sleep study in the hospital.